Nano-crystalline Megestrol Acetate Oral Suspension: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Nano-crystalline Megestrol Acetate Oral Suspension

• Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
  NCT07150663 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
  NCT06830018 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
  NCT06940102 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve Nano-crystalline Megestrol Acetate Oral Suspension?

3 recruiting trials across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.